Data Integrity, ALCOA+ & Part 11 / Annex 11

Spreadsheet Controls in GMP: Validation, Locking and Version Management Spreadsheet Controls in GMP: Validation, Locking and Version Management – Ensuring Data Integrity and Compliance Pharmaceutical manufacturers and associated stakeholders operating under Good Manufacturing Practice (GMP) regulations increasingly rely on electronic data systems, including spreadsheets, to manage critical quality and manufacturing information. Within the confines of…

Read More “Spreadsheet Controls in GMP: Validation, Locking and Version Management” »

Scan-to-PDF Practices: How to Avoid Losing Traceability and Metadata Ensuring Data Integrity in Scan-to-PDF Processes: A Step-by-Step Guide for Pharma Professionals In pharmaceutical manufacturing and associated regulated environments, maintaining data integrity is paramount, especially when converting hardcopy GxP records into electronic formats such as PDF. The process of scanning to PDF, if not carefully executed,…

Read More “Scan-to-PDF Practices: How to Avoid Losing Traceability and Metadata” »

Data Retention and Archiving Strategies That Protect Integrity Across the Lifecycle Data Retention and Archiving Strategies to Ensure Integrity Across the Pharmaceutical Product Lifecycle Pharmaceutical manufacturers operating within US, UK, and EU regulatory frameworks must prioritize data integrity throughout the entire product lifecycle to ensure patient safety, regulatory compliance, and manufacturing quality. This tutorial provides…

Read More “Data Retention and Archiving Strategies That Protect Integrity Across the Lifecycle” »

Legacy Systems and Standalone Instruments: Managing Data Integrity Risks Pragmatically Legacy Systems and Standalone Instruments: Practical Management of Data Integrity Risks in Pharma Managing data integrity risks in pharmaceutical manufacturing environments is increasingly complex as organizations contend with legacy systems and standalone instruments. These systems often predate modern regulatory requirements such as 21 CFR Part…

Read More “Legacy Systems and Standalone Instruments: Managing Data Integrity Risks Pragmatically” »

Ensuring Data Integrity in Electronic Batch Record (EBR) Implementations Step-by-Step Guide to Ensuring Data Integrity in Electronic Batch Record (EBR) Implementations Implementing electronic batch records (EBRs) in pharmaceutical manufacturing environments is a fundamental component of advancing manufacturing efficiency and regulatory compliance. However, the transition from paper-based systems to electronic systems brings critical responsibilities regarding data…

Read More “Ensuring Data Integrity in Electronic Batch Record (EBR) Implementations” »

Investigating Repeated Data Integrity Signals in the Same Lab or Unit Effective Investigation of Repeated Data Integrity Signals in Pharmaceutical Labs and Units Maintaining data integrity within pharmaceutical manufacturing and laboratory environments is fundamental to ensuring product quality, patient safety, and regulatory compliance. Recurring data integrity signals—whether deviations, anomalies, or non-compliances—identified repeatedly in the same…

Read More “Investigating Repeated Data Integrity Signals in the Same Lab or Unit” »

Embedding DI Requirements Into Technical and Quality Agreements With Vendors Embedding Data Integrity Requirements Into Technical and Quality Agreements With Vendors: A Step-by-Step Guide Ensuring robust data integrity in pharmaceutical manufacturing and clinical operations is fundamental for compliance with regulatory authorities globally, including the FDA, EMA, MHRA, and other GxP regulators. Embedding clear and enforceable…

Read More “Embedding DI Requirements Into Technical and Quality Agreements With Vendors” »

Data Integrity Oversight for Contract Labs and External Testing Partners Step-by-Step Guide to Data Integrity Oversight for Contract Labs and External Testing Partners In the pharmaceutical industry, data integrity remains a pillar of compliance and patient safety. The challenge magnifies when organizations engage with contract laboratories and external testing partners. These collaborations introduce complexities in…

Read More “Data Integrity Oversight for Contract Labs and External Testing Partners” »

Review by Exception vs Full Data Review: What Regulators Expect Under DI Understanding Review by Exception vs Full Data Review: Regulatory Expectations Under Data Integrity Ensuring data integrity in the pharmaceutical industry has been a key regulatory focus for agencies such as the US FDA, EMA, MHRA, and other global bodies. Critical to this is…

Read More “Review by Exception vs Full Data Review: What Regulators Expect Under DI” »

Data Integrity Risks in Standalone Lab Instruments and Portable Devices Managing Data Integrity Risks in Standalone Laboratory Instruments and Portable Devices Ensuring data integrity within pharmaceutical manufacturing and quality environments remains paramount to compliance with global regulatory frameworks such as 21 CFR Part 11, Annex 11 of the EU GMP guide, and guidance from agencies…

Read More “Data Integrity Risks in Standalone Lab Instruments and Portable Devices” »